Toxicity studies of 4-allyloxy-3-chlorophenylacetic acid, a new analgesic, antipyretic, and anti-inflammatory agent.
D000014:Abnormalities, Drug-Induced; D000632:Aminopyrine / Q000633:toxicity; D000700:Analgesics / Q000008:administration & dosage / Q000633:toxicity*; D000740:Anemia / Q000139:chemically induced; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000633:toxicity*; D001241:Aspirin / Q000633:toxicity; D001522:Behavior, Animal / Q000187:drug effects; D001769:Blood / Q000187:drug effects; D003061:Codeine / Q000633:toxicity; D003864:Depression, Chemical; D011431:Dextropropoxyphene / Q000633:toxicity; D004285:Dogs; D005260:Female; D006128:Growth / Q000187:drug effects; D000882:Haplorhini; D006410:Hematopoiesis / Q000187:drug effects; D008297:Male; D051379:Mice; D009747:Nutritional Physiological Phenomena; D009929:Organ Size; D010615:Phenacetin / Q000633:toxicity; D010648:Phenylacetates / Q000008:administration & dosage / Q000633:toxicity*; D010653:Phenylbutazone / Q000633:toxicity; D011247:Pregnancy; D051381:Rats; D013045:Species Specificity; D013268:Stimulation, Chemical
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D010648:Phenylacetates; D000632:Aminopyrine; D010615:Phenacetin; D010653:Phenylbutazone; D001241:Aspirin; D011431:Dextropropoxyphene; D003061:Codeine